Lv41
640 积分 2024-07-08 加入
Brentuximab vedotin in combination with lenalidomide and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma: Results from the phase 3 ECHELON-3 study
4个月前
已完结
International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes
4个月前
已完结
Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-cell, NK-cell and Stroma-Derived Neoplasms of Lymphoid Tissues
4个月前
已完结
A practical approach to the modern diagnosis and classification of T-and NK-cell lymphomas
4个月前
已完结
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
4个月前
已完结
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment
4个月前
已完结
皖公网安备34019202002308
